MenABCWY set to revolutionise the meningococcal vaccine market
29 June 2016 | By Victoria White, Digital Content Producer
GlobalData says MenABCWY has the potential to significantly change the approach used to prevent meningococcal disease...
List view / Grid view
News
Regorafenib increases overall survival in hepatocellular carcinoma study
29 June 2016 | By Victoria White, Digital Content Producer
Results from the Phase III RESORCE trial investigating Bayer’s regorafenib in patients with unresectable hepatocellular carcinoma have been announced...
FDA approves Epclusa for treatment of chronic HCV
29 June 2016 | By Victoria White, Digital Content Producer
Epclusa is the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection...
Psoriasis survey reveals discrimination and low treatment expectations
29 June 2016 | By Victoria White, Digital Content Producer
Findings from the largest global survey to date of people with psoriasis reveal 84% of people with moderate-to-severe psoriasis suffer discrimination...
Controversy, media coverage and statin use in the UK
28 June 2016 | By Victoria White, Digital Content Producer
A study has found that controversy over the risks and benefits of statins was followed by an increase in people stopping their statin treatment...
SPIRE-HR and SPIRE-FH trials of bococizumab meet primary endpoints
28 June 2016 | By Victoria White, Digital Content Producer
Two Phase III trials of Pfizer’s bococizumab, SPIRE-HR (HighRisk) and SPIRE-FH (Familial Hypercholesterolemia), met their primary endpoint...
Pfizer invests big in biosimilar production in China
28 June 2016 | By Victoria White, Digital Content Producer
Pfizer is to invest $350 million in the development of a state-of-the-art Global Biotechnology Centre in the Hangzhou Economic Development Area...
Results in from Phase III CHART-1 study of C-Cure
28 June 2016 | By Victoria White, Digital Content Producer
Celyad has announced headline results for CHART-1, its European Phase III clinical trial for its lead cardiovascular disease product candidate - C-Cure...
Ocrevus marketing applications under review by the EMA and FDA
28 June 2016 | By Victoria White, Digital Content Producer
If approved by the EMA and FDA for both indications, Ocrevus would be the first and only treatment for both forms of multiple sclerosis...
Novartis and Xencor enter bispecific antibody collaboration
28 June 2016 | By Victoria White, Digital Content Producer
The collaboration includes XmAb Bispecific Technology for 4 Novartis targets and access to Xencor Fc Technologies...
AstraZeneca’s new antibiotic Zavicefta approved in the EU
28 June 2016 | By Victoria White, Digital Content Producer
The EC has granted marketing authorisation for Zavicefta for the treatment of patients with serious Gram-negative bacterial infections...
Merck enters the IPF market through Afferent acquisition
27 June 2016 | By Victoria White, Digital Content Producer
Merck’s acquisition of Afferent Pharmaceuticals will provide it with an entry-platform into the fast-growing IPF market, according to GlobalData...
Sanofi and Boehringer Ingelheim reach next step in business swap
27 June 2016 | By Victoria White, Digital Content Producer
Sanofi and Boehringer Ingelheim have signed contracts to secure the exchange of Sanofi's Merial and Boehringer Ingelheim's consumer healthcare business...
CHMP positive opinion for Keytruda in NSCLC
27 June 2016 | By Victoria White, Digital Content Producer
The CHMP has recommended approval of Keytruda for the treatment of locally advanced or metastatic NSCLC in adults whose tumours express PD-L1...
GlobalData on the difficulties and opportunities of Brexit for pharma
27 June 2016 | By Victoria White, Digital Content Producer
While a Brexit undoubtedly creates significant issues for the UK pharma industry, opportunities remain for the sector to thrive, according to GlobalData...
